Table 3.
Anthropometric data before chemotherapy according to the regimens.
| Mean ± standard deviation | Median (minimum – maximum) | P | |
|---|---|---|---|
| Height (cm) | |||
| CAPOX (n = 106) | 163.73 ± 8.91 | 164 (136 − 178) | 0.142 |
| FOLFOX (n = 137) | 166.85 ± 9.34 | 168 (139 − 196) | |
| Weight (kg) | |||
| CAPOX (n = 106) | 72.5 ± 12.8 | 70.5 (45 − 99) | 0.645 |
| FOLFOX (n = 137) | 73.25 ± 12.36 | 71.5 (38 − 120) | |
| BMI (kg/m2) | |||
| CAPOX (n=106) | 27.06 ± 4.47 | 26.75 (17.78 − 43.16) | 0.196 |
| FOLFOX (n = 137) | 26.34 ± 4.14 | 26.1 (12.87 − 42.02) | |
| BSA (m2) | |||
| CAPOX (n = 106) | 1.77 ± 0.18 | 1.79 (1.32 − 2.1) | 0.335 |
| FOLFOX (n = 137) | 1.79 ± 0.16 | 1.8 (1.21 − 2.1) | |
| Age (years) | |||
| CAPOX (n = 106) | 63.37 ± 10.15 | 64 (39 − 83) | 0.036 |
| FOLFOX (n = 137) | 60.39 ± 9.72 | 62 (34 − 81) | |
| Operation to chemotherapy (days) | |||
| CAPOX (n = 106) | 45.6 ± 24.4 | 43 (13 − 229) | 0.602 |
| FOLFOX (n = 137) | 46.46 ± 21.69 | 44 (15 − 188) | |
CAPOX: capecitabine and oxaliplatin; FOLFOX: 5-fluorouracil, leucovorin, and oxaliplatin; BMI: body mass index; BSA: body surface area.